Summary

Blood Transfusion Diagnostics Market – Scope of Report
TMR’s report on the global blood transfusion diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global blood transfusion diagnostics market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global blood transfusion diagnostics market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the blood transfusion diagnostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global blood transfusion diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global blood transfusion diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global blood transfusion diagnostics market.

The report delves into the competitive landscape of the global blood transfusion diagnostics market. Key players operating in the global blood transfusion diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global blood transfusion diagnostics market profiled in this report.

Key Questions Answered in Global blood transfusion diagnostics Market Report
• What is the sales/revenue generated by blood transfusion diagnostics across all regions during the forecast period?
• What are the opportunities in the global blood transfusion diagnostics market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Blood Transfusion Diagnostics Market – Research Objectives and Research Approach
The comprehensive report on the global blood transfusion diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global blood transfusion diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global blood transfusion diagnostics market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Blood Transfusion Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, 2020-2034
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Epidemiology of Blood Disorders and Prevalence of Blood Transfusion Events
5.2. Blood Transfusion Products Pricing Analysis
5.3. Government Procurement Policies of Blood Transfusion Diagnostics
5.4. Key Industry Events (Partnerships, Collaborations, Product Approvals, Mergers and Acquisitions, Funding and investments)
5.5. Impact of COVID-19 Pandemic
6. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, By Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product Type, 2020-2034
6.3.1. Instruments
6.3.1.1. Blood Grouping Instruments
6.3.1.2. Others
6.3.2. Kits and Reagents
6.3.2.1. Blood Grouping Kits and Reagents
6.3.2.2. Others
6.4. Market Attractiveness By Product Type
7. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, By Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Application, 2020-2034
7.3.1. Blood Grouping
7.3.1.1. ABO Blood Grouping
7.3.1.2. Rh Blood Grouping
7.3.1.3. Red Blood Cell Antibody Screening
7.3.1.4. Extended Phenotyping
7.3.1.5. Cross Matching Tests
7.3.2. Disease Screening
7.3.2.1. Molecular Disease Screening
7.3.2.2. Serological Disease Screening
7.4. Market Attractiveness By Application
8. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, By End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By End-user, 2020-2034
8.3.1. Blood Banks
8.3.2. Blood Donation / Transfusion Centers
8.3.3. Others
8.4. Market Attractiveness By End-user
9. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Country/Region
10. North America Blood Transfusion Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Product Type, 2020-2034
10.2.1. Instruments
10.2.1.1. Blood Grouping Instruments
10.2.1.2. Others
10.2.2. Kits and Reagents
10.2.2.1. Blood Grouping Kits and Reagents
10.2.2.2. Others
10.3. Market Value Forecast By Application, 2020-2034
10.3.1. Blood Grouping
10.3.1.1. ABO Blood Grouping
10.3.1.2. Rh Blood Grouping
10.3.1.3. Red Blood Cell Antibody Screening
10.3.1.4. Extended Phenotyping
10.3.1.5. Cross Matching Tests
10.3.2. Disease Screening
10.3.2.1. Molecular Disease Screening
10.3.2.2. Serological Disease Screening
10.4. Market Value Forecast By End-user, 2020-2034
10.4.1. Blood Banks
10.4.2. Blood Donation / Transfusion Centers
10.4.3. Others
10.5. Market Value Forecast By Country, 2020-2034
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Blood Transfusion Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product Type, 2020-2034
11.2.1. Instruments
11.2.1.1. Blood Grouping Instruments
11.2.1.2. Others
11.2.2. Kits and Reagents
11.2.2.1. Blood Grouping Kits and Reagents
11.2.2.2. Others
11.3. Market Value Forecast By Application, 2020-2034
11.3.1. Blood Grouping
11.3.1.1. ABO Blood Grouping
11.3.1.2. Rh Blood Grouping
11.3.1.3. Red Blood Cell Antibody Screening
11.3.1.4. Extended Phenotyping
11.3.1.5. Cross Matching Tests
11.3.2. Disease Screening
11.3.2.1. Molecular Disease Screening
11.3.2.2. Serological Disease Screening
11.4. Market Value Forecast By End-user, 2020-2034
11.4.1. Blood Banks
11.4.2. Blood Donation / Transfusion Centers
11.4.3. Others
11.5. Market Value Forecast By Country, 2020-2034
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country
12. Asia Pacific Blood Transfusion Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product Type, 2020-2034
12.2.1. Instruments
12.2.1.1. Blood Grouping Instruments
12.2.1.2. Others
12.2.2. Kits and Reagents
12.2.2.1. Blood Grouping Kits and Reagents
12.2.2.2. Others
12.3. Market Value Forecast By Application, 2020-2034
12.3.1. Blood Grouping
12.3.1.1. ABO Blood Grouping
12.3.1.2. Rh Blood Grouping
12.3.1.3. Red Blood Cell Antibody Screening
12.3.1.4. Extended Phenotyping
12.3.1.5. Cross Matching Tests
12.3.2. Disease Screening
12.3.2.1. Molecular Disease Screening
12.3.2.2. Serological Disease Screening
12.4. Market Value Forecast By End-user, 2020-2034
12.4.1. Blood Banks
12.4.2. Blood Donation / Transfusion Centers
12.4.3. Others
12.5. Market Value Forecast By Country, 2020-2034
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country
13. Latin America Blood Transfusion Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product Type, 2020-2034
13.2.1. Instruments
13.2.1.1. Blood Grouping Instruments
13.2.1.2. Others
13.2.2. Kits and Reagents
13.2.2.1. Blood Grouping Kits and Reagents
13.2.2.2. Others
13.3. Market Value Forecast By Application, 2020-2034
13.3.1. Blood Grouping
13.3.1.1. ABO Blood Grouping
13.3.1.2. Rh Blood Grouping
13.3.1.3. Red Blood Cell Antibody Screening
13.3.1.4. Extended Phenotyping
13.3.1.5. Cross Matching Tests
13.3.2. Disease Screening
13.3.2.1. Molecular Disease Screening
13.3.2.2. Serological Disease Screening
13.4. Market Value Forecast By End-user, 2020-2034
13.4.1. Blood Banks
13.4.2. Blood Donation / Transfusion Centers
13.4.3. Others
13.5. Market Value Forecast By Country, 2020-2034
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country
14. Middle East & Africa Blood Transfusion Diagnostics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Product Type, 2020-2034
14.2.1. Instruments
14.2.1.1. Blood Grouping Instruments
14.2.1.2. Others
14.2.2. Kits and Reagents
14.2.2.1. Blood Grouping Kits and Reagents
14.2.2.2. Others
14.3. Market Value Forecast By Application, 2020-2034
14.3.1. Blood Grouping
14.3.1.1. ABO Blood Grouping
14.3.1.2. Rh Blood Grouping
14.3.1.3. Red Blood Cell Antibody Screening
14.3.1.4. Extended Phenotyping
14.3.1.5. Cross Matching Tests
14.3.2. Disease Screening
14.3.2.1. Molecular Disease Screening
14.3.2.2. Serological Disease Screening
14.4. Market Value Forecast By End-user, 2020-2034
14.4.1. Blood Banks
14.4.2. Blood Donation / Transfusion Centers
14.4.3. Others
14.5. Market Value Forecast By Country, 2020-2034
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Company Profiles
15.2.1. Grifols, S.A.
15.2.1.1. Company Overview
15.2.1.2. Financial Overview
15.2.1.3. Product Portfolio
15.2.1.4. Business Strategies
15.2.1.5. Recent Developments
15.2.2. Werfen, S.A.
15.2.2.1. Company Overview
15.2.2.2. Financial Overview
15.2.2.3. Product Portfolio
15.2.2.4. Business Strategies
15.2.2.5. Recent Developments
15.2.3. QuidelOrtho Corporation
15.2.3.1. Company Overview
15.2.3.2. Financial Overview
15.2.3.3. Product Portfolio
15.2.3.4. Business Strategies
15.2.3.5. Recent Developments
15.2.4. Abbott
15.2.4.1. Company Overview
15.2.4.2. Financial Overview
15.2.4.3. Product Portfolio
15.2.4.4. Business Strategies
15.2.4.5. Recent Developments
15.2.5. Bio-Rad Laboratories Inc.
15.2.5.1. Company Overview
15.2.5.2. Financial Overview
15.2.5.3. Product Portfolio
15.2.5.4. Business Strategies
15.2.5.5. Recent Developments
15.2.6. F. Hoffman La Roche Ltd.
15.2.6.1. Company Overview
15.2.6.2. Financial Overview
15.2.6.3. Product Portfolio
15.2.6.4. Business Strategies
15.2.6.5. Recent Developments
15.2.7. AliveDx Holdings Finance Company Ltd
15.2.7.1. Company Overview
15.2.7.2. Financial Overview
15.2.7.3. Product Portfolio
15.2.7.4. Business Strategies
15.2.7.5. Recent Developments
15.2.8. BAG Diagnostics GmbH
15.2.8.1. Company Overview
15.2.8.2. Financial Overview
15.2.8.3. Product Portfolio
15.2.8.4. Business Strategies
15.2.8.5. Recent Developments
15.2.9. Diasorin S.p.A.
15.2.9.1. Company Overview
15.2.9.2. Financial Overview
15.2.9.3. Product Portfolio
15.2.9.4. Business Strategies
15.2.9.5. Recent Developments
15.2.10. Prestige Diagnostics U.K. Ltd.
15.2.10.1. Company Overview
15.2.10.2. Financial Overview
15.2.10.3. Product Portfolio
15.2.10.4. Business Strategies
15.2.10.5. Recent Developments
15.2.11. Atlas Medical GmbH
15.2.11.1. Company Overview
15.2.11.2. Financial Overview
15.2.11.3. Product Portfolio
15.2.11.4. Business Strategies
15.2.11.5. Recent Developments
15.2.12. Lorne Laboratories Limited
15.2.12.1. Company Overview
15.2.12.2. Financial Overview
15.2.12.3. Product Portfolio
15.2.12.4. Business Strategies
15.2.12.5. Recent Developments